Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Advanced Medical Optics to close dealings and strengthen financing:

This article was originally published in Clinica

Executive Summary

Advanced Medical Optics (AMO) is expected to increase shareholder equity by $76m on closing a series of transactions. The company will exchange $83m of its outstanding notes for about 4.4 million common shares and $4.6m in cash. The move follows AMO's decision in April to acquire Pfizer's ophthalmic surgical business for a cash sum of $450m (see Clinica No 1105 ,p 19). A $76m non-cash charge will be recorded in the second quarter of 2004 on the note exchange. The Santa Ana, California-based company also added that its Japanese unit repaid a $22.4m term loan facility.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT058684

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel